🔥🐔 BizChicken 🐔🔥

Companies Similar to Embecta Corp.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Amgen Inc.

Amgen Inc. logo
Market Cap: Highest
Employees: Highest

Enbrel, Neulasta, Prolia, Xgeva, Otezla, Aranesp, KYPROLIS, Repatha, Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide, focusing on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience.

Tags: biotechnology, bone health, cardiovascular, healthcare, inflammation, neuroscience, oncology, pharmaceuticals, therapeutics

Symbol: AMGN

Recent Price: $259.30

Industry: Drug Manufacturers - General

CEO: Mr. Robert A. Bradway

Sector: Healthcare

Employees: 26700

Address: One Amgen Center Drive, Thousand Oaks, CA 91320-1799

Phone: 805 447 1000

Leadership

  • Robert A. Bradway, Chairman and Chief Executive Officer
  • James Bradner, Executive Vice President, Research and Development, and Chief Scientific Officer
  • Sean Bruich, Senior Vice President Artificial Intelligence and Data
  • Paul Burton, Senior Vice President and Chief Medical Officer
  • Raymond Deshaies, Senior Vice President, Global Research
  • Jackie Elbonne, Senior Vice President, Quality and Chief Quality Officer
  • Murdo Gordon, Executive Vice President, Global Commercial Operations
  • Jonathan Graham, Executive Vice President and General Counsel and Secretary
  • Peter Griffith, Executive Vice President and Chief Financial Officer
  • Nancy Grygiel, Senior Vice President, Worldwide Compliance & Business Ethics and Chief Compliance Officer
  • Narimon Honarpour, Senior Vice President, Global Development
  • Vikram Karnani, Executive Vice President, and President, Global Commercial Operations and Medical Affairs (Rare Disease)
  • My Linh Kha, Senior Vice President and General Manager, Japan Asia-Pacific
  • Rachna Khosla, Senior Vice President, Business Development
  • Gilles Marrache, Senior Vice President, Regional General Manager
  • Derek Miller, Senior Vice President, Human Resources
  • Jerry Murry, Senior Vice President, Process Development
  • Kave Niksefat, Senior Vice President, Global Marketing and Access
  • Arleen Paulino, Senior Vice President, Manufacturing
  • Annalisa Pizzarello, Senior Vice President, Results Delivery Office
  • Greg Portner, Senior Vice President, Global Government Affairs and Policy
  • Anton Rabushka, Senior Vice President, Finance
  • Emily Razaqi, Senior Vice President, Obesity and Related Conditions
  • David M. Reese, Executive Vice President and Chief Technology Officer
  • Esteban Santos, Executive Vice President, Operations
  • Darryl Sleep, Senior Vice President, Global Medical
  • Jean-Charles Soria, Senior Vice President, Research and Development
  • Susan Sweeney, Executive Vice President, Obesity and Related Conditions
  • Mark J. Taisey, Senior Vice President, Global Regulatory Affairs and Strategy
  • Susie Tappouni, Head of Corporate Affairs
  • Ian Thompson, Senior Vice President, U.S. Business Operations
  • Brenda Torres, Senior Vice President, Global Supply Chain
  • Alper Üreten, Vice President, Commercialization and Program Management
  • Wanda M. Austin, Retired President and Chief Executive Officer, The Aerospace Corporation
  • Michael V. Drake, President, University of California
  • Brian J. Druker, Physician-Scientist and Professor of Medicine, Oregon Health & Science University (OHSU), Director of the OHSU Knight Cancer Institute and JELD-WEN Chair of Leukemia Research, and Associate Dean for Oncology, OHSU School of Medicine
  • Robert A. Eckert, Lead Independent Director, Chairman Emeritus, Mattel, Inc.
  • Greg C. Garland, Former Executive Chairman and Former Chairman and Chief Executive Officer, Phillips 66
  • Charles M. Holley, Jr., Former Executive Vice President and Chief Financial Officer of Wal-Mart Stores, Inc.
  • S. Omar Ishrak, Former Executive Chairman and Chairman of the Board of Directors, Medtronic plc
  • Tyler Jacks, David H. Koch Professor of Biology, Massachusetts Institute of Technology and Founding Director of the David H. Koch Institute for Integrative Cancer Research
  • Mary E. Klotman, Executive Vice President for Health Affairs of Duke University, Dean of the Duke University School of Medicine, and Chief Academic Officer of Duke Health
  • Ellen J. Kullman, Executive Chair of the Board and Former President and Chief Executive Officer of Carbon, Inc.
  • Amy E. Miles, Former Chair of the Board and Chief Executive Officer, Regal Entertainment Group, Inc.

Last updated: 2024-12-31

Embecta Corp.

Embecta Corp. logo
Market Cap: Medium
Employees: High

pen needles, syringes, safety devices, digital applications

Embecta Corp. is a medical device company focused on providing solutions to enhance the health and wellbeing of people living with diabetes. Its offerings include products like pen needles, syringes, safety devices, and digital applications, with a primary market of wholesalers and distributors in the US and internationally.

Tags: diabetes, digital health, healthcare, medical devices, pen needles, syringes

Symbol: EMBC

Recent Price: $20.50

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Devdatt Kurdikar

Sector: Healthcare

Employees: 2200

Address: 300 Kimball Drive, Parsippany, NJ 07054

Phone: 201 847 6880

Last updated: 2024-12-31

Nemaura Medical Inc.

Nemaura Medical Inc. logo
Market Cap: Lowest
Employees: Lowest

sugar BEAT

Nemaura Medical Inc. is a medical technology company that develops and commercializes diagnostic medical devices, including a non-invasive continuous glucose monitoring device for diabetes management.

Tags: continuous glucose monitoring, diabetes, diagnostic devices, medical technology, wellness

Symbol: NMRD

Recent Price: $0.00

Industry: Medical - Devices

CEO: Dr. Dewan Fazlul Hoque Chowdhury Ph.D.

Sector: Healthcare

Employees: 36

Address: 57 West 57th Street, New York, NY 10019

Phone: 646 416 7912

Last updated: 2024-12-31

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. logo
Market Cap: Highest
Employees: Highest

EYLEA, Dupixent, Libtayo, Praluent, REGEN-COV, Kevzara, Inmazeb

Regeneron Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes medicines for treating various diseases worldwide, including treatments like EYLEA, Dupixent, Libtayo, and more.

Tags: biotechnology, diseases, healthcare, injections, medicines, pharmaceuticals, treatment

Symbol: REGN

Recent Price: $702.59

Industry: Biotechnology

CEO: Dr. Leonard S. Schleifer M.D., Ph.D.

Sector: Healthcare

Employees: 14165

Address: 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707

Phone: 914 847 7000

Leadership

  • Leonard S. Schleifer, MD, PhD, Board co-Chair, President and Chief Executive Officer
  • George D. Yancopoulos, MD, PhD, Board co-Chair, President and Chief Scientific Officer
  • Zoran Berkovic, Senior Vice President, Financial Planning and Analysis
  • Maya Bermingham, Senior Vice President, Public Policy and Government Affairs
  • Leonard Brooks, Senior Vice President, Treasurer
  • John Calabro, Senior Vice President, Internal Audit
  • Christina Chan, Senior Vice President, Corporate Affairs
  • Larry Coury, PhD, Senior Vice President, Associate General Counsel
  • Ryan Crowe, Senior Vice President, Investor Relations & Strategic Analysis
  • Matthew Everett, Senior Vice President, Global Procurement
  • Chris Fenimore, Senior Vice President, Finance and Chief Financial Officer
  • Rick Hall, Senior Vice President, Human Resources
  • Justin Holko, Senior Vice President, Global Oncology/Hematology Commercial Business Unit
  • Nouhad Husseini, Senior Vice President, Business Development
  • Joseph J. LaRosa, Executive Vice President, General Counsel and Secretary
  • Melissa Lozner, Senior Vice President, Chief Compliance Officer
  • Marion McCourt, Executive Vice President, Commercial
  • Bob McCowan, Senior Vice President, IT and Chief Information Officer
  • Gonzalo Merino, PhD, Senior Vice President, Chief Intellectual Property Counsel and Associate General Counsel
  • Richard O’Neal, Senior Vice President, Market Access
  • Sally A. Paull, Executive Vice President, Human Resources
  • Smita Pillai, Senior Vice President, Culture and DEI and Chief DEI Officer
  • George Poth, Senior Vice President, Real Estate & Facilities Management
  • Alessandra Ravetti, Senior Vice President, Associate General Counsel
  • Kerry Reinertsen, PhD, Senior Vice President, Strategic Alliances
  • David Snow, Senior Vice President, Global Head, Dupixent Franchise
  • Mark Volpe, Senior Vice President, Tax
  • Bola Akinlade, MD, FACP, Senior Vice President, Clinical Development, Immunology and Inflammation
  • Hanne Bak, PhD, Senior Vice President, Preclinical Manufacturing and Process Development
  • Aris Baras, MD, Senior Vice President, Regeneron Genetics Center®
  • Ned Braunstein, MD, Executive Vice President, Regulatory Affairs and Global Patient Safety
  • Gang Chen, PhD, Senior Vice President, Protein Expression Sciences
  • Thomas DiCioccio, PhD, Senior Vice President, Pharmacometrics
  • Benjamin Drosman, Senior Vice President, Global Development Quality & Regulatory Compliance
  • Gregory Geba, MD, PhD, Senior Vice President, Global Development Scientific Council
  • Philip Gregory, DPhil, Senior Vice President, Regeneron Cell Medicines
  • Gary Herman, MD, Senior Vice President, Early Clinical Development and Experimental Sciences
  • Boaz Hirshberg, MD, Senior Vice President, Clinical Sciences General Medicine
  • Diana Hughes, MBBS, Senior Vice President, Global Patient Safety
  • Bari Kowal, Senior Vice President, Development Operations and Portfolio Management
  • Christos Kyratsous, PhD, Senior Vice President, Research
  • Johnathan Lancaster, MD, PhD, Senior Vice President, Global Medical Affairs
  • John Lin, MD, PhD, Senior Vice President, Immuno-Oncology and Head of Bispecifics
  • Israel Lowy, MD, PhD, Senior Vice President, Translational and Clinical Sciences, Oncology
  • Lynn Macdonald, PhD, Senior Vice President, Research
  • Lori Morton, PhD, Senior Vice President, Research
  • Andrew Murphy, PhD, Executive Vice President, Research
  • Muriel O'Byrne, PhD, Senior Vice President, International Regulatory Affairs & Head, European Business Office
  • William Olson, PhD, Senior Vice President, Therapeutic Proteins
  • Mohammed Shameem, PhD, Senior Vice President, Formulations Development
  • L. Andres Sirulnik, MD, PhD, Senior Vice President, Translational and Clinical Sciences, Hematology
  • Randy Soltys, PhD, Senior Vice President, Drug Safety and Pharmacometrics
  • Neil Stahl, PhD, Executive Vice President, Research and Development
  • Robert Vitti, MD, Senior Vice President, Clinical Trial Excellence Strategy
  • Brian Zambrowicz, PhD, Executive Vice President, Functional Genomics and Chief VelociGene® Operations
  • Rajesh Ahuja, Senior Vice President, Fill/Finish and External Manufacturing
  • Frederick Austin, Senior Vice President, Quality Control, Raheen
  • Christine Childrose, Senior Vice President, Human Resources and HR Operations
  • David Crenshaw, Senior Vice President, Associate General Counsel
  • Tikiri Dissanayake, Senior Vice President, IOPS Technical Operations
  • Patrice Gilooly, Senior Vice President, Quality Assurance and Operations
  • Jennifer McNay, PhD, Senior Vice President, CMC Regulatory Sciences and Industrial Affairs
  • Niall O’Leary, Senior Vice President and Site Head, IOPS Raheen
  • Scott Oberman, Senior Vice President, Supply Chain Operations
  • David Simon, Senior Vice President, IOPS Finance and Business Operations
  • Daniel Van Plew, Executive Vice President and General Manager, Industrial Operations and Product Supply
  • Benjamin Yocum, Senior Vice President, Manufacturing Operations
  • James Wolfe, Senior Vice President, Process Sciences and Drug Product Engineering
  • Bonnie L. Bassler, PhD, Director
  • Michael S. Brown, MD, Director
  • N. Anthony Coles, MD, Chair of the Board
  • Joseph L. Goldstein, MD, Director
  • Kathryn Guarini, PhD, Director
  • Christine A. Poon, Lead Independent Director
  • Arthur F. Ryan, Director
  • Huda Y. Zoghbi, MD, Director
  • Samantha Dickon, Director, Development Program Management
  • Gervasio Batista, Sr. Scientist, Neuroscience
  • James K. Gibson, Senior Regional Director, Immunology/Pulmonary
  • Beth Brause, Director, Field Reimbursement Management
  • Eric Prendergast, Director, Pricing Strategy
  • Ashley Neff, Manager, Digital Communications
  • Shari Loock, Associate Director, Sourcing
  • Jennifer Davidson Hamilton, VP and Head of Precision Medicine
  • Yi Zhang, Director, Health Economics & Outcomes Research
  • Wilson Caldwell III, Director, GCO Vendor & Relationship Management
  • David Stein, Director, Medical Operations
  • Regeneron, Corporate
  • Grant Anicete, Biotech Production Specialist I / IOPS Rensselaer
  • Mary McKenna, Lead Quality Control Analyst / IOPS Raheen
  • Ashley Lebby, Lead Senior Biotech Production Specialist / IOPS Rensselaer
  • Varenka Rodriguez Diblasi, Principal Scientist, Bioinformatics
  • Jessie Brown, Manager, Integrative Translational Genetics
  • Gisu Eom, Lead Cloud DevOps Engineer
  • Carmen Kenworthy, Scientist, Velocigene
  • Ralph Hazlewood, Sr. Manager, Research Program Management
  • Brandy Bennett, Sr. Director, R&D Strategy & Operations

Last updated: 2024-12-31

Vaccinex, Inc.

Vaccinex, Inc. logo
Market Cap: Lowest
Employees: Lowest

pepinemab

Vaccinex, Inc., a clinical-stage biotechnology company, focuses on developing targeted biotherapeutics for cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate, pepinemab, is in clinical trials for multiple serious conditions.

Tags: autoimmune disorders, biotechnology, biotherapeutics, cancer, clinical trials, neurodegenerative diseases

Symbol: VCNX

Recent Price: $1.11

Industry: Biotechnology

CEO: Dr. Maurice Zauderer Ph.D.

Sector: Healthcare

Employees: 37

Address: 1895 Mount Hope Avenue, Rochester, NY 14620

Phone: 585 271 2700

Last updated: 2024-12-31

Becton, Dickinson and Company

Becton, Dickinson and Company logo
Market Cap: Highest
Employees: Highest

Medical supplies, devices, laboratory equipment, diagnostic products

Becton, Dickinson and Company develops, manufactures, and sells medical products for healthcare, including IV systems, medication delivery, and diagnostic solutions.

Tags: Diagnostic Products, Healthcare, Laboratory Equipment, Medical Devices, Medical Supplies

Symbol: BDX

Recent Price: $226.51

Industry: Medical - Instruments & Supplies

CEO: Mr. Thomas E. Polen Jr.

Sector: Healthcare

Employees: 70000

Address: 1 Becton Drive, Franklin Lakes, NJ 07417-1880

Phone: 201 847 6800

Last updated: 2024-12-31

Baxter International Inc.

Baxter International Inc. logo
Market Cap: Highest
Employees: Highest

Healthcare Products

Baxter International Inc. develops and provides a wide range of healthcare products worldwide, including dialysis therapies, intravenous and infusion therapies, medical devices for surgery, and patient monitoring technologies.

Tags: Dialysis, Healthcare, Medical Devices, Patient Monitoring, Pharmaceuticals

Symbol: BAX

Recent Price: $28.63

Industry: Medical - Instruments & Supplies

CEO: Mr. Jose E. Almeida

Sector: Healthcare

Employees: 60000

Address: One Baxter Parkway, Deerfield, IL 60015

Phone: 224 948 2000

Last updated: 2024-12-31

Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Highest

Emverm, Rytary, Unithroid

Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products across various dosage forms and therapeutic areas, operating through Generics, Specialty, and Av KARE segments.

Tags: Generics, Healthcare, Pharmaceuticals, Specialty, Therapeutics

Symbol: AMRX

Recent Price: $7.83

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Chirag K. Patel

Sector: Healthcare

Employees: 7850

Address: 400 Crossing Boulevard, Bridgewater, NJ 08807

Phone: 908 947 3120

Leadership

  • Chirag Patel, President and Co-Chief Executive Officer
  • Chintu Patel, Co-Chief Executive Officer
  • Tasos Konidaris, Executive Vice President, Chief Financial Officer
  • Nikita Shah, Executive Vice President, Chief Human Resources Officer
  • Jason B. Daly, Esq., Senior Vice President, Chief Legal Officer & Corporate Secretary
  • Gregory Sgammato, Senior Vice President, Corporate Development
  • Andrew S. Boyer, Executive Vice President, Chief Commercial Officer – Generics
  • Joe Renda, Senior Vice President, Chief Commercial Officer - Specialty
  • Shyamakant Giri, President, India Business & Emerging Markets
  • Sanjay Kumar Jain, PhD, Chief Quality Officer
  • Srinivas Kone, PhD, Senior Vice President, Chief Scientific Officer – Generics
  • Richard D’Souza, PhD, Senior Vice President, Specialty R&D
  • Maryll W. Toufanian, Senior Vice President, Regulatory Strategy and Government Affairs
  • Pranav Mehta, Senior Vice President, Strategic Sourcing & Supply Management
  • Sandeep R. Raktate, President, Operations – India & Ireland

Last updated: 2024-12-31

West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. logo
Market Cap: Highest
Employees: Highest

containment and delivery systems for injectable drugs and healthcare products

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products globally. They operate in two segments: Proprietary Products and Contract-Manufactured Products, offering solutions like stoppers, seals, syringe components, and advanced drug delivery technologies.

Tags: drug delivery, healthcare products, injectable drugs, packaging systems, pharmaceutical

Symbol: WST

Recent Price: $328.82

Industry: Medical - Instruments & Supplies

CEO: Mr. Eric M. Green

Sector: Healthcare

Employees: 10600

Address: 530 Herman O. West Drive, Exton, PA 19341-0645

Phone: 610 594 2900

Last updated: 2024-12-31

Cerus Corporation

Cerus Corporation logo
Market Cap: Low
Employees: Medium

INTERCEPT Blood System

Cerus Corporation is focused on enhancing blood safety through its INTERCEPT Blood System, a technology designed to reduce blood-borne pathogens in donated blood components for transfusion.

Tags: INTERCEPT Blood System, biomedical, blood safety, pathogen reduction, transfusion

Symbol: CERS

Recent Price: $1.55

Industry: Medical - Devices

CEO: Mr. William M. Greenman

Sector: Healthcare

Employees: 625

Address: 1220 Concord Avenue, Concord, CA 94520

Phone: 925 288 6000

Last updated: 2024-12-31

Curis, Inc.

Curis, Inc. logo
Market Cap: Lowest
Employees: Lowest

Emavusertib

Curis, Inc. is a biotechnology company focused on discovering and developing drug candidates for treating human cancers, with a range of clinical stage and pipeline products targeting lymphomas, leukemia, and solid tumors.

Tags: biotechnology, cancer treatment, clinical trials, drug development, oncology

Symbol: CRIS

Recent Price: $3.14

Industry: Biotechnology

CEO: Mr. James E. Dentzer

Sector: Healthcare

Employees: 49

Address: Building C, Lexington, MA 02421

Phone: 617 503 6500

Leadership

  • Martyn D. Greenacre, Chair of the Board
  • John Hohneker, M.D., Director
  • Kenneth I. Kaitin, Ph.D., Director
  • Anne E. Borgman, M.D., Director
  • Marc Rubin, M.D., Director
  • James Dentzer, Chief Executive Officer and Director

Last updated: 2024-12-31

ICU Medical, Inc.

ICU Medical, Inc. logo
Market Cap: High
Employees: Highest

medical devices

ICU Medical, Inc. develops, manufactures, and sells medical devices for infusion therapy and critical care applications worldwide.

Tags: catheter, critical care, healthcare, hemodialysis, infusion therapy, medical devices, needlefree

Symbol: ICUI

Recent Price: $154.20

Industry: Medical - Instruments & Supplies

CEO: Mr. Vivek Jain

Sector: Healthcare

Employees: 14000

Address: 951 Calle Amanecer, San Clemente, CA 92673

Phone: 949 366 2183

Last updated: 2024-12-31

Indaptus Therapeutics, Inc.

Indaptus Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

Decoy20

Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company focusing on the development of anti-cancer and anti-viral immunotherapy products, with its lead clinical candidate, Decoy20, targeting lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as viral infections.

Tags: Decoy20, anti-cancer, anti-viral, biotechnology, immunotherapy

Symbol: INDP

Recent Price: $0.87

Industry: Biotechnology

CEO: Mr. Jeffrey A. Meckler

Sector: Healthcare

Employees: 7

Address: 3 Columbus Circle, New York, NY 10019

Phone: 347 480 9760

Last updated: 2024-12-31

Sharps Technology, Inc.

Sharps Technology, Inc. logo
Market Cap: Lowest
Employees: Lowest

Sharps Provensa

Sharps Technology Inc. is a medical device company that researches, designs, develops, manufactures, and sells safety syringe products, including the ultra-low waste space syringe Sharps Provensa, in the United States.

Tags: collaboration, healthcare, innovation, medical device, safety syringes

Symbol: STSS

Recent Price: $2.03

Industry: Medical - Instruments & Supplies

CEO: Mr. Robert M. Hayes

Sector: Healthcare

Employees: 57

Address: 105 Maxess Road, Melville, NY 11747

Phone: 631-574-4436

Last updated: 2024-12-31

Virpax Pharmaceuticals, Inc.

Virpax Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

Epoladerm, Probudur, Envelta, PES200, An Qlar, VRP324

Virpax Pharmaceuticals, Inc. is a preclinical-stage pharmaceutical company dedicated to developing drug-delivery systems and technologies for non-opioid, non-addictive pain management and treatments for central nervous system disorders.

Tags: Envelta, Epoladerm, Probudur, central nervous system, drug-delivery, non-opioid, pain management, pharmaceutical, preclinical

Symbol: VRPX

Recent Price: $0.45

Industry: Biotechnology

CEO: Mr. Jatinder Dhaliwal

Sector: Healthcare

Employees: 7

Address: 1055 Westlakes Drive, Berwyn, PA 19312

Phone: 610 727 4597

Last updated: 2024-12-31

Penumbra, Inc.

Penumbra, Inc. logo
Market Cap: Highest
Employees: High

Penumbra System

Penumbra, Inc. designs, develops, manufactures, and markets medical devices, including aspiration-based thrombectomy systems, accessory devices, neurovascular embolization coiling systems, and neurosurgical aspiration tools, serving the United States and international markets.

Tags: Embolization, Medical Devices, Neurosurgical Tools, Neurovascular, Thrombectomy Systems

Symbol: PEN

Recent Price: $238.18

Industry: Medical - Devices

CEO: Mr. Adam Elsesser

Sector: Healthcare

Employees: 4200

Address: One Penumbra Place, Alameda, CA 94502

Phone: 510 748 3200

Last updated: 2024-12-31

Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Low

Ryanodex, Belrapzo, Bendeka, EP-4104, PEMFEXY, EA-114, Vasopressin

Eagle Pharmaceuticals, Inc. specializes in the development and commercialization of pharmaceutical products targeting diseases of the central nervous system, metabolic critical care, and oncology in the U.S. Notable products include Ryanodex for malignant hyperthermia, and oncology treatments Belrapzo and Bendeka.

Tags: antitoxin, central nervous system, collaboration agreements, critical care, disease treatment, oncology, pharmaceutical

Symbol: EGRX

Recent Price: $0.50

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Michael Graves

Sector: Healthcare

Employees: 134

Address: 50 Tice Boulevard, Woodcliff Lake, NJ 07677

Phone: 201 326 5300

Last updated: 2024-12-31

Insulet Corporation

Insulet Corporation logo
Market Cap: Highest
Employees: High

Omnipod System

Insulet Corporation develops, manufactures, and sells insulin delivery systems, offering the Omnipod System, a tubeless device for insulin-dependent diabetes management.

Tags: diabetes management, healthcare, innovation, insulin delivery, medical devices

Symbol: PODD

Recent Price: $263.36

Industry: Medical - Devices

CEO: Dr. James R. Hollingshead Ph.D.

Sector: Healthcare

Employees: 3000

Address: 100 Nagog Park, Acton, MA 01720

Phone: 978 600 7000

Last updated: 2024-12-31

Nektar Therapeutics

Nektar Therapeutics logo
Market Cap: Low
Employees: Low

Bempegaldesleukin

Nektar Therapeutics is a biopharmaceutical company focused on developing medicines for unmet medical needs. Their products include Bempegaldesleukin, an IL-2 pathway agonist in clinical trials for various cancers and COVID-19, and NKTR-358, a cytokine Treg stimulant for autoimmune diseases.

Tags: autoimmune diseases, biopharmaceutical, clinical trials, medicines, oncology

Symbol: NKTR

Recent Price: $0.94

Industry: Biotechnology

CEO: Mr. Howard W. Robin

Sector: Healthcare

Employees: 137

Address: 455 Mission Bay Boulevard South, San Francisco, CA 94158

Phone: 415 482 5300

Leadership

  • Howard W. Robin, President & Chief Executive Officer
  • Robert Bacci, Senior Vice President, HR and Facilities Operations
  • Sandra Gardiner, Chief Financial Officer
  • Jennifer Ruddock, Chief Business Officer
  • Mary Tagliaferri, M.D., Chief Medical Officer
  • Mark A. Wilson, Chief Legal Officer
  • Jonathan Zalevsky, Ph.D., Chief Research & Development Officer

Last updated: 2024-12-31

Nortech Systems Incorporated

Nortech Systems Incorporated logo
Market Cap: Lowest
Employees: Medium

Electromedical and Electromechanical Systems

Nortech Systems Incorporated provides design and manufacturing solutions for electromedical devices, electromechanical systems, assemblies, and components. They offer services including project management, design, testing, prototyping, and manufacturing across markets such as aerospace, defense, medical, and industrial.

Tags: Aerospace, Defense, Electromechanical, Electromedical, Industrial, Manufacturing, Medical Devices

Symbol: NSYS

Recent Price: $10.13

Industry: Hardware, Equipment & Parts

CEO: Mr. Jay Dean Miller

Sector: Technology

Employees: 733

Address: 7550 Meridian Circle North, Maple Grove, MN 55369

Phone: 952 345 2244

Last updated: 2024-12-31